<SEC-DOCUMENT>0001193125-20-219417.txt : 20200814
<SEC-HEADER>0001193125-20-219417.hdr.sgml : 20200814
<ACCEPTANCE-DATETIME>20200813215334
ACCESSION NUMBER:		0001193125-20-219417
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200813
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200814
DATE AS OF CHANGE:		20200813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMGEN INC
		CENTRAL INDEX KEY:			0000318154
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				953540776
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37702
		FILM NUMBER:		201101080

	BUSINESS ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320
		BUSINESS PHONE:		(805)447-1000

	MAIL ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMGEN
		DATE OF NAME CHANGE:	19870305
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d96041d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amgn="http://www.amgen.com/20200813" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-08-13_to_2020-08-13">AMGEN INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-08-13_to_2020-08-13">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-08-13_to_2020-08-13">0000318154</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="amgn-20200813.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-08-13_to_2020-08-13"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-13</xbrli:startDate> <xbrli:endDate>2020-08-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-13</xbrli:startDate> <xbrli:endDate>2020-08-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A1.250SeniorNotesDue2022Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-13</xbrli:startDate> <xbrli:endDate>2020-08-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318154</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A2.00SeniorNotesDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-13</xbrli:startDate> <xbrli:endDate>2020-08-13</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-08-13_to_2020-08-13">8-K</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt:datemonthdayyearen">August 13, 2020</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Amgen Inc.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-08-13_to_2020-08-13">001-37702</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-08-13_to_2020-08-13">95-3540776</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:49%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-08-13_to_2020-08-13">One Amgen Center Drive</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-08-13_to_2020-08-13">Thousand Oaks</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-08-13_to_2020-08-13">91320-1799</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-08-13_to_2020-08-13">(805)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-08-13_to_2020-08-13">447-1000</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common stock, $0.0001 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">AMGN</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Global Select Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">1.250% Senior Notes Due 2022</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">AMGN22</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">2.000% Senior Notes Due 2026</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">AMGN26</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-08-13_to_2020-08-13" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;13, 2020, Amgen Inc. (the &#8220;Company&#8221;) issued a press release announcing the early results of its previously announced private offers to exchange certain outstanding debt securities of the Company for a combination of a cash payment and new debt securities of the Company (the &#8220;Exchange Offers&#8221;). A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;13, 2020, the Company also issued a press release announcing (i)&#160;the pricing terms of the Exchange Offers, (ii)&#160;increase of the cap on the aggregate principal amount of new debt securities to be issued in the Exchanges Offers from $800,000,000 to $940,000,000 and (iii)&#160;the Company&#8217;s acceptance of outstanding debt securities tendered in the Exchange Offers. A copy of the press release is attached as Exhibit 99.2 to this report and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Document Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d96041dex991.htm">Press Release dated August&#160;13, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d96041dex992.htm">Press Release dated August&#160;13, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3">AMGEN INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: August&#160;13, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Justin G. Claeys</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Justin G. Claeys</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Vice President, Finance and Treasurer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d96041dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g96041g0813072937572.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B><I>News Release</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Amgen Center Drive</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thousand Oaks, CA
91320-1799</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1000</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.Amgen.com</P></TD></TR>
</TABLE> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SENIOR NOTES EXCHANGE OFFERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THOUSAND
OAKS, Calif. (August 13, 2020) &#150; Amgen Inc. (NASDAQ:AMGN) announced today the early tender results of its previously announced nine separate private offers to exchange (each, an &#147;Exchange Offer&#148; and, collectively, the &#147;Exchange
Offers&#148;) certain specified series of its outstanding senior notes (collectively, the &#147;Old Notes&#148;) for a combination of a cash payment and new Senior Notes due 2053 (the &#147;New Notes&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exchange Offers consist of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) an offer to exchange the 6.90% Senior Notes due 2038; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) an offer to exchange the 6.375% Senior Notes due 2037; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) an offer to exchange the 6.40% Senior Notes due 2039; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) an offer to exchange the 5.75% Senior Notes due 2040; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) an offer to exchange the 5.65% Senior Notes due 2042; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) an offer to exchange the 5.375% Senior Notes due 2043; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) an offer to exchange the 5.15% Senior Notes due 2041; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) an offer to exchange the 4.95% Senior Notes due 2041; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) an offer to exchange the 4.40% Senior Notes due 2045; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, for a combination of a cash payment and New Notes, provided that the aggregate principal amount of New Notes to be issued in the Exchange Offers
shall not exceed $800,000,000 (such amount, the &#147;Maximum Notes Exchange Cap&#148;). In addition, the aggregate amount of the New Notes Premium (as defined in the Confidential Offering Circular (as defined herein)) resulting from the Exchange
Offers shall not exceed $350,000,000 (such amount, the &#147;Maximum New Notes Premium Cap&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exchange Offers are being conducted by Amgen upon
the terms and subject to the conditions set forth in a confidential offering circular, dated July&nbsp;30, 2020 (the &#147;Confidential Offering Circular&#148;). The Exchange Offers are only intended for, and copies of the offering documents will
only be made available to, holders of outstanding Old Notes that have certified their status as (1)&nbsp;a &#147;Qualified Institutional Buyer&#148; as defined in Rule 144A under the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;), in a private transaction in reliance upon the exemption from the registration requirements of the Securities Act provided by Section&nbsp;4(a)(2) thereof, or (2) (A) a person other than a &#147;U.S. person&#148; (as defined in Rule 902
of Regulation S under the Securities Act), outside the United States not purchasing for the account or benefit of a U.S. person, (B)&nbsp;acquiring the New Notes in an offshore transaction in accordance with Regulation S under the Securities Act and
(C)&nbsp;otherwise a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Qualified Offeree (as described in the Confidential Offering Circular) (each such holder, an &#147;Exchange Eligible Holder&#148; and, collectively, the &#147;Exchange Eligible
Holders&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
2</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Documents relating to the Exchange Offers have been and will be distributed only to holders of the
outstanding Old Notes that have completed or will complete and have returned or will return the letter of eligibility confirming that they are Exchange Eligible Holders. Holders of the outstanding Old Notes that desire to review the eligibility
letter may visit the website for this purpose at <B><U>http://www.dfking.com/amgn</U></B> or contact D.F. King&nbsp;&amp; Co., Inc. (&#147;D.F. King&#148;), the exchange agent and information agent for the Exchange Offers, by calling toll-free (800)
<FONT STYLE="white-space:nowrap">814-8954</FONT> or at (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (banks and brokerage firms) or by email at amgen@dfking.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on information provided by D.F. King, the following aggregate principal amount of each series of Old Notes was validly tendered and not validly
withdrawn at or prior to the Early Participation Date (as defined herein) pursuant to the Exchange Offers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CUSIP/ISIN Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Old Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acceptance&nbsp;Priority<BR>Level</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>Tendered&nbsp;by&nbsp;the&nbsp;Early<BR>Participation Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162AY6/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162AY66</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.90% Senior Notes due 2038</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">290,616,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162AW0/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162AW01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.375% Senior Notes due 2037</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">552,410,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,531,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BA7/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BA71</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.40% Senior Notes due 2039</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">466,320,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">133,310,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BC3/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BC38</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.75% Senior Notes due 2040</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 412,120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,022,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BH2/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BH25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.65% Senior Notes due 2042</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">487,020,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,602,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BP4/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BP41</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.375% Senior Notes due 2043</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261,077,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,199,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BK5/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BK53</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.15% Senior Notes due 2041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">974,045,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">491,030,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BE9/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BE93</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.95% Senior Notes due 2041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">600,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">323,794,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">031162BZ2/</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">US031162BZ23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.40% Senior Notes due 2045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">939,837,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>&nbsp;</B></TD>
<TD VALIGN="top" ALIGN="right"><B>Total:</B></TD>
<TD NOWRAP VALIGN="top"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,185,660,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions of the Exchange Offers, Amgen will accept for exchange the Old Notes of any series validly
tendered, and not validly withdrawn, in the Exchange Offers in accordance with the applicable &#147;Acceptance Priority Level&#148; (in numerical priority order) for such series as set forth in the table above (each, an &#147;Acceptance Priority
Level&#148;), with Acceptance Priority Level&nbsp;1 being the highest priority level. Subject to the Maximum Notes Exchange Cap and/or the Maximum New Notes Premium Cap, each series of Old Notes validly tendered in the Exchange Offers that has a
higher Acceptance Priority Level will be accepted for exchange before </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
3</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any series of Old Notes validly tendered in the Exchange Offers that has a lower Acceptance Priority Level. If the remaining available portion of the Maximum Notes Exchange Cap or the Maximum New
Notes Premium Cap, as applicable, is not adequate to permit the acceptance for exchange of all of the validly tendered Old Notes of a series having a particular Acceptance Priority Level, Amgen will allocate such available Maximum Notes Exchange Cap
or Maximum New Notes Premium Cap, as applicable, among the aggregate principal amount of the validly tendered Old Notes of such series on a pro rata basis, and any series of validly tendered Old Notes having a lower Acceptance Priority Level than at
which proration occurs will not be accepted for exchange. As set forth in the Confidential Offering Circular, Amgen may elect, in its sole discretion, to increase the Maximum Notes Exchange Cap and/or the Maximum New Notes Premium Cap, but is under
no obligation to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All Old Notes that are tendered for exchange in the Exchange Offers on or before the Early Participation Date will have priority
over Old Notes that are tendered for exchange after the Early Participation Date. If the principal amount of Old Notes validly tendered and not validly withdrawn on or before the Early Participation Date constitutes a principal amount of Old Notes
that, if accepted by Amgen, would result in Amgen issuing New Notes having an aggregate principal amount equal to or in excess of the Maximum Notes Exchange Cap, unless Amgen elects, in its sole discretion, to increase the Maximum Notes Exchange
Cap, Amgen will not accept any Old Notes tendered for exchange after the Early Participation Date (even if they are of Acceptance Priority Level&nbsp;1). In addition, if the aggregate amount of the New Notes Premium resulting from Old Notes tendered
for exchange in the Exchange Offers on or before the Early Participation Date, and accepted by Amgen, equals or exceeds the Maximum New Notes Premium Cap, unless Amgen elects, in its sole discretion, to increase the Maximum New Notes Premium Cap,
Amgen will not accept any Old Notes tendered for exchange after the Early Participation Date (even if they are of Acceptance Priority Level&nbsp;1). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
withdrawal date (5:00 p.m., New York City time, on August&nbsp;12, 2020) for the Exchange Offers has now passed. In accordance with the terms of the Exchange Offers, tendered Old Notes may no longer be withdrawn, except in certain limited
circumstances where additional withdrawal rights are required by law.&nbsp;The Exchange Offers will expire at 12:00 Midnight, New York City time, at the end of August&nbsp;26, 2020, unless extended by Amgen (such date and time, as it may be
extended, the &#147;Expiration Date&#148;). The prices for the New Notes offered in the Exchange Offers will be determined at 10:00 a.m., New York City time, on August&nbsp;13, 2020, unless extended by Amgen (such date and time, as it may be
extended, the &#147;Price Determination Date&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exchange Eligible Holders that validly tendered and did not validly withdraw their Old Notes at or
prior to 5:00 p.m., New York City time, on August&nbsp;12, 2020 (the &#147;Early Participation Date&#148;) will be eligible to receive the applicable Total Exchange Price (as defined in the Confidential Offering Circular), which includes an early
exchange premium equal to $30.00 in principal amount of New Notes for each $1,000 principal amount of the applicable series of Old Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date and accepted for exchange
(the &#147;Early Exchange Premium&#148;). Exchange Eligible Holders of Old Notes who validly tender their Old Notes after the Early Participation Date, but at or prior to the Expiration Date, will be eligible to receive the applicable Exchange Price
(as defined in the Confidential Offering Circular), but will not receive the Early Exchange Premium. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Total Exchange Price payable by Amgen for each
$1,000 principal amount of Old Notes tendered for exchange, and accepted by Amgen, will consist of a combination of cash and a principal amount of New Notes (together, a &#147;Payment Amount&#148;) equal to the applicable Total Exchange Price of the
series of Old Notes tendered. The Exchange Prices will be paid in the same manner as the Total Exchange Prices except that the principal amount of New Notes </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
4</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constituting a portion of the Payment Amount will be reduced by the Early Exchange Premium. The Total Exchange Price will be calculated on the Price Determination Date, unless extended by Amgen.
Amgen may, at its option, elect to increase or decrease the principal amount of New Notes exchangeable for each $1,000 principal amount of the applicable Old Notes tendered and accepted by up to $100 per $1,000 principal amount. Such adjustments
would affect the composition, but not the amount, of the Total Exchange Price and the Exchange Price for such series of Old Notes. Amgen expects any such election to be made as of the Price Determination Date. In addition to the applicable Total
Exchange Price or applicable Exchange Price, Exchange Eligible Holders whose Old Notes are accepted for exchange will be paid accrued and unpaid interest on such Old Notes to, but not including, the applicable Settlement Date (as defined herein) in
cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen reserves the right, but is under no obligation, at any point following the Early Participation Date and before the Expiration Date, to accept
for exchange any Old Notes validly tendered at or prior to the Early Participation Date (the date of such exchange, the &#147;Early Settlement Date&#148;). The Early Settlement Date will be determined at Amgen&#146;s option and is currently expected
to occur on August&nbsp;17, 2020, the third business day immediately following the Early Participation Date. If, after the Early Participation Date, Amgen chooses to exercise its option to have an Early Settlement Date and all conditions to the
relevant Exchange Offers have been or are concurrently satisfied or waived by Amgen, including satisfaction or waiver of the Accounting Treatment Condition, the Minimum Issue Condition and the Yield Condition (each as defined in the Confidential
Offering Circular), and subject to each of the Maximum Notes Exchange Cap and the Maximum New Notes Premium Cap, Amgen will accept for exchange all Old Notes validly tendered in the Exchange Offers prior to the Early Participation Date, and the
exchange for such Old Notes will be made on the Early Settlement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whether or not Amgen chooses to exercise its option to have an Early Settlement
Date, if, at or prior to the Expiration Date, all conditions to the relevant Exchange Offer have been or concurrently are satisfied or waived by Amgen, including satisfaction or waiver of the Accounting Treatment Condition, the Minimum Issue
Condition and the Yield Condition, and subject to each of the Maximum Notes Exchange Cap and the Maximum New Notes Premium Cap, Amgen will accept for exchange all Old Notes validly tendered in such Exchange Offer at or prior to the Expiration Date,
and not validly withdrawn at or prior to the Withdrawal Date (the date of such exchange, the &#147;Final Settlement Date&#148;).The Final Settlement Date for the Exchange Offers will be promptly after the Expiration Date and is currently expected to
occur on August&nbsp;28, 2020, the second business day immediately following the Expiration Date. Each of the Early Settlement Date and the Final Settlement Date is referred to as a &#147;Settlement Date.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consummation of the Exchange Offers is subject to the satisfaction of certain conditions, including the absence of certain adverse legal and market
developments. The complete terms of the Exchange Offers are described in the Confidential Offering Circular. Amgen reserves the right, subject to applicable law, to extend, terminate or otherwise amend the terms of any or all of the Exchange Offers.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If and when issued, the New Notes will not be registered under the Securities Act or any state securities laws. Therefore, the New Notes may not be
offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and any applicable state securities laws. Amgen will enter into a registration rights agreement with respect
to the New Notes providing for certain registration rights with respect to the New Notes as described in the Confidential Offering Circular. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
5</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release is not an offer to sell or a solicitation of an offer to buy any security. The Exchange
Offers are being made solely by the Confidential Offering Circular and only to such persons and in such jurisdictions as is permitted under applicable law. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>In particular, this communication is only addressed to and directed at: (A)&nbsp;in any Member State of the European Economic Area or the United Kingdom
that has implemented the Prospectus Directive, qualified investors in that Member State within the meaning of the Prospectus Directive and (B)&nbsp;(i) persons that are outside the United Kingdom or (ii)&nbsp;persons in the United Kingdom who are
investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#147;Order&#148;) or fall within Article 43 of the Order, or any other person to whom it may otherwise
lawfully be communicated under the Order (all such persons together being referred to as &#147;relevant persons&#148;). The New Notes are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such New
Notes will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Amgen </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen&nbsp;is committed to unlocking
the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the
complexities of disease and understand the fundamentals of human biology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen&nbsp;focuses on areas of high unmet medical need and leverages its
expertise to strive for solutions that improve health outcomes and dramatically improve people&#146;s lives. A biotechnology pioneer since 1980,&nbsp;Amgen&nbsp;has grown to be one of the world&#146;s leading independent biotechnology companies, has
reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of
historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company, including Adaptive
Biotechnologies (including statements regarding such collaboration&#146;s, or our own, ability to discover and develop fully-human neutralizing antibodies targeting
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> to potentially prevent or treat <FONT STYLE="white-space:nowrap">COVID-19),</FONT> BeiGene, Ltd., or the
Otezla<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (apremilast) acquisition, including anticipated Otezla sales growth and the timing of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> EPS accretion, as well as estimates of revenues,
operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes,
effects of pandemics or other widespread health problems such as the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business, outcomes, progress or effects relating to studies of Otezla as a potential treatment for <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> the completion of the Exchange Offers and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described
in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent periodic reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT>
and current reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements
contained in this document as a result of new information, future events or otherwise. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
6</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No forward-looking statement can be guaranteed and actual results may differ materially from those we
project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched
products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny
and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward
managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify
safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may
be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to
significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to
prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our
manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the
distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product sales, product development, business and results of operations.
We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our
marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product
is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices
and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product
similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other
companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. A breakdown, cyberattack or information security breach could compromise the
confidentiality, integrity and availability of our systems and data. Our stock price is volatile and may be affected by a number of events. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or
our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES EARLY TENDER RESULTS OF SENIOR NOTES EXCHANGE OFFERS</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PAGE </B><B>
7</B>
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT: Amgen, Thousand Oaks </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trish Rowland, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-5631</FONT></FONT> (media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Megan Fox, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">805-447-1423</FONT></FONT> (media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Arvind Sood,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1060</FONT></FONT> (investors) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d96041dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g96041g0813072937572.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Amgen Center Drive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thousand Oaks, CA 91320-1799</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1000</FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.Amgen.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>News Release </I></B></P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMGEN ANNOUNCES PRICING TERMS FOR
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SENIOR NOTES EXCHANGE OFFERS, INCREASES THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MAXIMUM NOTES EXCHANGE CAP AND ACCEPTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TENDERED NOTES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THOUSAND OAKS, Calif.
(August 13, 2020) &#150; Amgen Inc. (NASDAQ:AMGN) announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an &#147;Exchange Offer&#148; and, collectively, the &#147;Exchange Offers&#148;) certain
specified series of its outstanding senior notes (collectively, the &#147;Old Notes&#148;) for a combination of a cash payment and new Senior Notes due 2053 (the &#147;New Notes&#148;). In addition, Amgen announced that it has increased the cap on
the aggregate principal amount of New Notes to be issued in the Exchange Offers from $800,000,000 to $940,000,000 (such increased amount, the &#147;Maximum Notes Exchange Cap&#148;). Except for the increase in the Maximum Notes Exchange Cap
described above, all other terms and conditions of the Exchange Offers remain unchanged. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exchange Offers consist of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) an offer to exchange the 6.90% Senior Notes due 2038; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) an offer to exchange the 6.375% Senior Notes due 2037; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) an offer to exchange the 6.40% Senior Notes due 2039; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) an offer to exchange the 5.75% Senior Notes due 2040; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) an offer to exchange the 5.65% Senior Notes due 2042; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) an offer to exchange the 5.375% Senior Notes due 2043; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) an offer to exchange the 5.15% Senior Notes due 2041; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) an offer to exchange the 4.95% Senior Notes due 2041; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) an offer to exchange the 4.40% Senior Notes due 2045; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES PRICING TERMS OF SENIOR NOTES EXCHANGE OFFERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B> PAGE
 2
 </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, for a combination of a cash payment and New Notes, provided that the aggregate principal amount
of New Notes to be issued in the Exchange Offers shall not exceed the Maximum Notes Exchange Cap and/or the Maximum New Notes Premium Cap (as defined in the Confidential Offering Circular). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Exchange Offers are being conducted by Amgen upon the terms and subject to the conditions set forth in a confidential offering circular, dated
July&nbsp;30, 2020 (the &#147;Confidential Offering Circular&#148;). The Exchange Offers are only intended for, and copies of the offering documents will only be made available to, holders of outstanding Old Notes that have certified their status as
(1)&nbsp;a &#147;Qualified Institutional Buyer&#148; as defined in Rule 144A under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), in a private transaction in reliance upon the exemption from the registration requirements of
the Securities Act provided by Section&nbsp;4(a)(2) thereof, or (2) (A) a person other than a &#147;U.S. person&#148; (as defined in Rule 902 of Regulation S under the Securities Act), outside the United States not purchasing for the account or
benefit of a U.S. person, (B)&nbsp;acquiring the New Notes in an offshore transaction in accordance with Regulation S under the Securities Act and (C)&nbsp;otherwise a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Qualified Offeree (as described
in the Confidential Offering Circular) (each such holder, an &#147;Exchange Eligible Holder&#148; and, collectively, the &#147;Exchange Eligible Holders&#148;). Documents relating to the Exchange Offers have been and will be distributed only to
holders of the outstanding Old Notes that have completed or will complete and have returned or will return the letter of eligibility confirming that they are Exchange Eligible Holders. Holders of the outstanding Old Notes that desire to review the
eligibility letter may visit the website for this purpose at <U>http://www.dfking.com/amgn</U> or contact D.F. King&nbsp;&amp; Co., Inc., the exchange agent and information agent for the Exchange Offers, by calling toll-free (800) <FONT
STYLE="white-space:nowrap">814-8954</FONT> or at (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (banks and brokerage firms) or by email at amgen@dfking.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table indicates, among other things, the Total Exchange Price (as defined herein) and the amount of cash payment for each $1,000 principal
amount of the applicable series of Old Notes subject to the Exchange Offers, as calculated at 10:00 a.m., New York City time, on August&nbsp;13, 2020 (such date and time, the &#147;Price Determination Date&#148;) in accordance with the Confidential
Offering Circular: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Composition&nbsp;of&nbsp;Total</B><br><B>Exchange&nbsp;Price<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>CUSIP/ISIN Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Old&nbsp;Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Reference</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>U.S. Treasury<BR>Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acceptance<BR>Priority<BR>Level</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Yield&nbsp;of&nbsp;Reference<BR>U.S. Treasury</B><br><B>Security at Price<BR>Determination</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fixed</B><br><B>Spread</B><br><B>(basis</B><br><B>points)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exchange<BR>Offer</B><br><B>Yield</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Early<BR>Exchange<BR>Premium<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Exchange<BR>Price<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal<BR>Amount&nbsp;of<BR>New Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162AY6/US031162AY66</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">6.90% Senior Notes due 2038</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due&nbsp;February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,654.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,392.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162AW0/US031162AW01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">6.375% Senior Notes due 2037</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due&nbsp;February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.320</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,561.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,314.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">246.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BA7/US031162BA71</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">6.40% Senior Notes due 2039</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due&nbsp;February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,599.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,383.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">215.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BC3/US031162BC38</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5.75% Senior Notes due 2040</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due&nbsp;February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.420</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,516.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,377.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">139.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BH2/US031162BH25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5.65% Senior Notes due 2042</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due&nbsp;February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.470</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,524.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,419.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">104.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BP4/US031162BP41</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5.375% Senior Notes due 2043</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.470</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,494.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,445.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BK5/US031162BK53</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5.15% Senior Notes due 2041</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.420</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,443.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,394.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BE9/US031162BE93</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">4.95% Senior Notes&nbsp;due 2041</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.470</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,406.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,381.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">031162BZ2/US031162BZ23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">4.40% Senior Notes due 2045</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">2.000% UST due February&nbsp;15, 2050</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.620</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,317.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,317.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES PRICING TERMS OF SENIOR NOTES EXCHANGE OFFERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B> PAGE
 3
 </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Old Notes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Does not reflect any accrued and unpaid interest. Amgen will pay accrued and unpaid interest on the Old Notes
to, but not including, the Early Settlement Date (as defined herein) in cash. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The figures in this table reflect any optional adjustments of the principal amount of New Notes exchangeable
for each $1,000 principal amount of the applicable series of Old Notes tendered and accepted for exchange, as permitted under the terms and conditions in the Confidential Offering Circular. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below indicates the interest rate (the &#147;New Notes Coupon&#148;) for the New Notes to be issued by Amgen pursuant to the Exchange Offers, as
calculated at the Price Determination Date in accordance with the Confidential Offering Circular: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>New Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Reference U.S.<BR>Treasury Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Yield&nbsp;of&nbsp;Reference&nbsp;U.S.<BR>Treasury&nbsp;Security&nbsp;at&nbsp;Price<BR>Determination Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Spread<BR>(basis<BR>points)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>New&nbsp;Notes<BR>Coupon</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Notes due 2053</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2.000%&nbsp;UST&nbsp;due&nbsp;February&nbsp;15,&nbsp;2050</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.370</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">+140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.770</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the Acceptance Priority Levels and proration procedures described in the Confidential Offering Circular,
Amgen will accept $676,157,000 in aggregate principal amount of the Old Notes that were tendered for exchange at or prior to the Early Participation Date. Amgen expects to deliver an aggregate principal amount of $940,000,000 of New Notes and will
pay an aggregate of $85,382,998.17 cash consideration, excluding accrued and unpaid interest, for the Old Notes accepted for exchange on the Early Settlement Date. Since Old Notes have been validly tendered as of the Early Participation Date so that
the maximum amount of New Notes to be issued in exchange for such tendered Old Notes would exceed the Maximum Notes Exchange Cap, no additional Old Notes will be accepted for exchange after the Early Participation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below indicates, among other things, the principal amount of each series of Old Notes validly tendered as of the Early Participation Date, the
principal amount of Old Notes to be accepted for exchange as of the Early Participation Date and the percentage of the principal amount of Old Notes to be accepted for exchange pursuant to the Exchange Offers: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>CUSIP/ISIN Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Old&nbsp;Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount<BR>Tendered&nbsp;by&nbsp;Early<BR>Participation Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;to<BR>be Accepted for<BR>Exchange</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proration&nbsp;Factor</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162AY6/US031162AY66</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.90%&nbsp;Senior&nbsp;Notes&nbsp;due 2038</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,335,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162AW0/US031162AW01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.375%&nbsp;Senior&nbsp;Notes&nbsp;due 2037</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,531,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,531,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BA7/US031162BA71</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6.40% Senior Notes due 2039</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">133,310,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">133,310,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BC3/US031162BC38</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.75% Senior Notes due 2040</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,022,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,022,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BH2/US031162BH25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.65% Senior Notes due 2042</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,602,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,602,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BP4/US031162BP41</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.375% Senior Notes due 2043</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,199,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76,199,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BK5/US031162BK53</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.15% Senior Notes due 2041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">491,030,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">245,158,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49.977</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BE9/US031162BE93</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.95% Senior Notes due 2041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">323,794,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">031162BZ2/US031162BZ23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.40% Senior Notes due 2045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">939,837,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES PRICING TERMS OF SENIOR NOTES EXCHANGE OFFERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B> PAGE
 4
 </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The withdrawal date (5:00 p.m., New York City time, on August&nbsp;12, 2020) for the Exchange Offers has now
passed. In accordance with the terms of the Exchange Offers, tendered Old Notes may no longer be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law. The Exchange Offers will expire at 12:00
Midnight, New York City time, at the end of August&nbsp;26, 2020, unless extended by Amgen (such date and time, as it may be extended, the &#147;Expiration Date&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exchange Eligible Holders that validly tendered and did not validly withdraw their Old Notes at or prior to the Early Participation Date will be eligible to
receive the applicable Total Exchange Price set forth in the first table above (each, a &#147;Total Exchange Price&#148;), which includes an early exchange premium equal to $30.00 in principal amount of New Notes for each $1,000 principal amount of
the applicable series of Old Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date and accepted for exchange (the &#147;Early Exchange Premium&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the applicable Total Exchange Price, Exchange Eligible Holders whose Old Notes are accepted for exchange will be paid accrued and unpaid
interest on such Old Notes to, but not including, the Early Settlement Date in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen has elected to conduct an early settlement for Old Notes
tendered at or prior to the Early Participation Date and accepted by Amgen. Such early settlement is expected to occur on August&nbsp;17, 2020 (the &#147;Early Settlement Date&#148;), subject to all the conditions to the Exchange Offers having been
satisfied or waived by Amgen. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The complete terms of the Exchange Offers are described in the Confidential Offering Circular. Amgen reserves the right,
subject to applicable law, to extend, terminate or otherwise amend the terms of any or all of the Exchange Offers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If and when issued, the New Notes will
not be registered under the Securities Act or any state securities laws. Therefore, the New Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act
and any applicable state securities laws. Amgen will enter into a registration rights agreement with respect to the New Notes providing for certain registration rights with respect to the New Notes as described in the Confidential Offering Circular.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release is not an offer to sell or a solicitation of an offer to buy any security. The Exchange Offers are being made solely by the
Confidential Offering Circular and only to such persons and in such jurisdictions as is permitted under applicable law. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>In particular, this
communication is only addressed to and directed at: (A)&nbsp;in any Member State of the European Economic Area or the United Kingdom that has implemented the Prospectus Directive, qualified investors in that Member State within the meaning of the
Prospectus Directive and (B)&nbsp;(i) persons that are outside the United Kingdom or (ii)&nbsp;persons in the United Kingdom who are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the &#147;Order&#148;) or fall within Article 43 of the Order, or any </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES PRICING TERMS OF SENIOR NOTES EXCHANGE OFFERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B> PAGE
 5
 </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
other person to whom it may otherwise lawfully be communicated under the Order (all such persons together being referred to as &#147;relevant persons&#148;). The New Notes are only available to,
and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such New Notes will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Amgen </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen&nbsp;is committed to
unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the
complexities of disease and understand the fundamentals of human biology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amgen&nbsp;focuses on areas of high unmet medical need and leverages its
expertise to strive for solutions that improve health outcomes and dramatically improve people&#146;s lives. A biotechnology pioneer since 1980,&nbsp;Amgen&nbsp;has grown to be one of the world&#146;s leading independent biotechnology companies, has
reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of
historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company, including Adaptive
Biotechnologies (including statements regarding such collaboration&#146;s, or our own, ability to discover and develop fully-human neutralizing antibodies targeting
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> to potentially prevent or treat <FONT STYLE="white-space:nowrap">COVID-19),</FONT> BeiGene, Ltd., or the
Otezla<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (apremilast) acquisition, including anticipated Otezla sales growth and the timing of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> EPS accretion, as well as estimates of revenues,
operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes,
effects of pandemics or other widespread health problems such as the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business, outcomes, progress or effects relating to studies of Otezla as a potential treatment for <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> the completion of the Exchange Offers and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described
in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent periodic reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT>
and current reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements
contained in this document as a result of new information, future events or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No forward-looking statement can be guaranteed and actual results
may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future
products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by
pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline
developments and domestic and international trends toward </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AMGEN ANNOUNCES PRICING TERMS OF SENIOR NOTES EXCHANGE OFFERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B> PAGE
 6
 </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government
regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and
product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and
the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or
circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also
depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution
of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product sales, product development, business and results of operations. We rely on
collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed
products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is
uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and
component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product
similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other
companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. A breakdown, cyberattack or information security breach could compromise the
confidentiality, integrity and availability of our systems and data. Our stock price is volatile and may be affected by a number of events. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or
our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT: Amgen, Thousand Oaks </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trish Rowland, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-5631</FONT></FONT> (media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Megan Fox, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1423</FONT></FONT> (media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Arvind Sood, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">805-447-1060</FONT></FONT> (investors) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>amgn-20200813.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/14/2020 5:18:00 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:amgn="http://www.amgen.com/20200813"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amgen.com/20200813"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20200813_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20200813_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amgn-20200813_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="amgn_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="amgn_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="amgn_A1.250SeniorNotesDue2022Member" name="A1.250SeniorNotesDue2022Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="amgn_A2.00SeniorNotesDue2026Member" name="A2.00SeniorNotesDue2026Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>amgn-20200813_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/14/2020 5:18:05 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20200813.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A1.250SeniorNotesDue2022Member" xlink:type="locator" xlink:label="amgn_A1.250SeniorNotesDue2022Member" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="amgn_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A1.250SeniorNotesDue2022Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A2.00SeniorNotesDue2026Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>amgn-20200813_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/14/2020 5:18:00 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="amgn_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="amgn_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A1.250SeniorNotesDue2022Member" xlink:type="locator" xlink:label="amgn_A1.250SeniorNotesDue2022Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_A1.250SeniorNotesDue2022Member" xlink:to="amgn_A1.250SeniorNotesDue2022Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_A1.250SeniorNotesDue2022Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 1.250 Senior Notes Due 2022 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_A1.250SeniorNotesDue2022Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 1.250 Senior Notes Due 2022 [Member]</link:label>
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amgn_A2.00SeniorNotesDue2026Member" xlink:to="amgn_A2.00SeniorNotesDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="amgn_A2.00SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 2.00 Senior Notes Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="amgn_A2.00SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 2.00 Senior Notes Due 2026 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>amgn-20200813_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/14/2020 5:18:02 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amgn-20200813.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="amgn_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="amgn_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="amgn_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A1.250SeniorNotesDue2022Member" xlink:type="locator" xlink:label="amgn_A1.250SeniorNotesDue2022Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A1.250SeniorNotesDue2022Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="amgn-20200813.xsd#amgn_A2.00SeniorNotesDue2026Member" xlink:type="locator" xlink:label="amgn_A2.00SeniorNotesDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amgn_A2.00SeniorNotesDue2026Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amgn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g96041g0813072937572.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g96041g0813072937572.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% ,L# 2(  A$! Q$!_\0
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M-/[S'H*^?;Z^N-2O9;RZD,DTK;F8_P OI7'@<'[9\T_A7XG?F./^KKDA\3_
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MH1Q?8[<0DF,G<1WZU+KX6-2,H66]]/(M8;&SI3C4N[VM=^?J>;>$?^1NTO\
MZ[BO4OB7HZZCX::\1?W]D=X/^R>&'\C^%96C?#"YTO6;2_;5(I%@D#E!$03^
MM>A7MLM[87%J_P!V:-HSQZC%<^*Q4'7A4IN]CIP6#FL/.E55KGS-7M7PM_Y%
M#_MX?^E<]_PJ&[_Z"\/_ 'Y/^-=UX2T"3PWHWV"2X6=O,9]ZKM'-:X_%4JM+
ME@[NYCEN#KT:W-.-E8W:***\4]\**** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d96041d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:amgn="http://www.amgen.com/20200813"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amgn-20200813.xsd" xlink:type="simple"/>
    <context id="duration_2020-08-13_to_2020-08-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
        </entity>
        <period>
            <startDate>2020-08-13</startDate>
            <endDate>2020-08-13</endDate>
        </period>
    </context>
    <context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-13</startDate>
            <endDate>2020-08-13</endDate>
        </period>
    </context>
    <context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A1.250SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-13</startDate>
            <endDate>2020-08-13</endDate>
        </period>
    </context>
    <context id="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318154</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amgn:A2.00SeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-13</startDate>
            <endDate>2020-08-13</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-08-13_to_2020-08-13"
      id="Hidden_dei_EntityRegistrantName">AMGEN INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-08-13_to_2020-08-13">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-08-13_to_2020-08-13"
      id="Hidden_dei_EntityCentralIndexKey">0000318154</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-08-13_to_2020-08-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-08-13_to_2020-08-13">2020-08-13</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-08-13_to_2020-08-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-08-13_to_2020-08-13">001-37702</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-08-13_to_2020-08-13">95-3540776</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-08-13_to_2020-08-13">One Amgen Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-08-13_to_2020-08-13">Thousand Oaks</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-08-13_to_2020-08-13">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-08-13_to_2020-08-13">91320-1799</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-08-13_to_2020-08-13">(805)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-08-13_to_2020-08-13">447-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-08-13_to_2020-08-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-08-13_to_2020-08-13">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-08-13_to_2020-08-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-08-13_to_2020-08-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">AMGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">1.250% Senior Notes Due 2022</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">AMGN22</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A1.250SeniorNotesDue2022Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">2.000% Senior Notes Due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">AMGN26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-08-13_to_2020-08-13_us-gaap-StatementClassOfStockAxis_amgn-A2.00SeniorNotesDue2026Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-08-13_to_2020-08-13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140119104517704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 13, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMGEN INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 13,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3540776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Amgen Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Thousand Oaks<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91320-1799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">447-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amgn_A1.250SeniorNotesDue2022Member', window );">A 1.250 Senior Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.250% Senior Notes Due 2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member', window );">A 2.00 Senior Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amgn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.000% Senior Notes Due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMGN26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amgn_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amgn_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amgn_A1.250SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amgn_A1.250SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amgn_A2.00SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME3S._7W<NF>*Y^GA,,SVLS@L=L!^[E>K$_V'ZU6143<-4-RS_T4VT3H#LBK
M"ME*0#<+T%JSP$W"U=KVYP=0,!O+O&5IZ:JL0K 2[6C1CGNTS5N^R)#A(_ER
MQ^U@Q);GU'DU#=YB/T"= U/<+^<\S)1MQ:=+LA F+C6Y"I%#/K3-QQGYWKL
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M_8'F_L;(;7Z(N)3&R"2_W' &ZR#[ /R^DM CAQM[+ED<*P__ E!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "PK@U1'#AEZC\!   \ @  #P
M 'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$N)0^D*H6E8K[DG6(
MQ3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@
MR*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R '<(Y_<Z[
M5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+BLX5>C(,=D",Y1]X
MVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M#,,SQ;;!<.AH
MQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >"CVN*!.L>@PL
M(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DNR94;4EWI>::W
M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ L*X-420>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( +"N#5%ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " "PK@U1GS'%I^X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "PK@U1
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( +"N#5%. &R?Y 0  &(6   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "PK@U1
M@ZFE ]0!   R!@  #0              @ $G#0  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( +"N#5&7BKL<P    !,"   +              "  28/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( +"N#5$<.&7J/P$  #P"   /
M      "  0\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "PK@U1)!Z;
MHJT   #X 0  &@              @ %[$0  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " "PK@U199!YDAD!  #/ P  $P
M    @ %@$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "J
%$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d96041d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d96041d8k.htm">d96041d8k.htm</File>
    <File>amgn-20200813.xsd</File>
    <File>amgn-20200813_def.xml</File>
    <File>amgn-20200813_lab.xml</File>
    <File>amgn-20200813_pre.xml</File>
    <File>d96041dex991.htm</File>
    <File>d96041dex992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d96041d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "amgn-20200813_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "d96041d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amgn-20200813_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amgn-20200813_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "amgn-20200813.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "amgn",
   "nsuri": "http://www.amgen.com/20200813",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d96041d8k.htm",
      "contextRef": "duration_2020-08-13_to_2020-08-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d96041d8k.htm",
      "contextRef": "duration_2020-08-13_to_2020-08-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "amgn_A1.250SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "A 1.250 Senior Notes Due 2022 [Member]",
        "terseLabel": "A 1.250 Senior Notes Due 2022 [Member]"
       }
      }
     },
     "localname": "A1.250SeniorNotesDue2022Member",
     "nsuri": "http://www.amgen.com/20200813",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "amgn_A2.00SeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "A 2.00 Senior Notes Due 2026 [Member]",
        "terseLabel": "A 2.00 Senior Notes Due 2026 [Member]"
       }
      }
     },
     "localname": "A2.00SeniorNotesDue2026Member",
     "nsuri": "http://www.amgen.com/20200813",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "amgn_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://www.amgen.com/20200813",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "amgn_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://www.amgen.com/20200813",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.amgen.com//20200813/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-20-219417-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-219417-xbrl.zip
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M,JFY2_V8N5&'4W/&]>17J">A.;W(=(7P)Z9=)EE"VF964S+Z@!MVW&-E^B@
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M:S:MIOP?6X]3@%T.GK<:/O OKI_Z:B(SZ D?&T5_'C#N."XNTBJ!G0&+WV<
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MA!9G!Z:5FIN.\ H^O<.F@F_.[4IJ$73KD^NJE_6+136H'\6$*8Q6KTGP2:>
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M;PJD]>($FM9*+P"IF KIS@1(*R\ :6<JI),8M59] 5"[4T$M3X"T_ *0]J9
M6BLV)D.*=F'IT,JIT$Y0 +5Z2M?MD[,_P)\T*45*ZF#&8,"B^,X7PU8*\R@C
M"."E7.:G+<#BBGWNW_*[B%(EGZY8Z^S?0(GJNAV2LIK[OS3HWTBRSKB_QZ?G
M$+4\/N7YG$G/AT.MBP]L6LRSC#@"@62739@32%%!<J1APV#"E/=F9/DI]T:3
ML<](8'";T*%'%QC<KUG]X]0/=<!-53?2L_[M=!>VL#:W#QOUT"4$/Q_%31B'
M>;)+B=!M&T<TO2N=\!(<10E7\,8-<,,]T8&P)YW[6 4=B;I! L0T/X8:QS)T
M$Y^'F\5I&N?YW$H>"B 30H*.<.+& '#[SH07R4!IV#-W.4K:?T,PA-2EX"+S
MGB-!7GJ,'C\M<PY=9=%U#;H.\V )O<+:_R7^G6;&:DG'HOD@:#K-TAAA$F(J
M@"A4@KX)D(4 .,>X_ ,3^.%,*6R><A/DP8C=2@P4\&'@H#[W@.MNN/1YVP=2
M*(?UE._A'#!"/FQ, T+-K3U^(RCNU.$FS"5#T)P\3@"Z"(+P\J;&G!ML_YE@
M>([WG@51+.,$"0N('R5W6>P[Q%=7"4!4KM6:$)UX0C-F2[A)"&L"8#1=BA?*
MC2K$^? D[VM*Y"@\?+>AJ*.7T,;I<<B#B+LDL?!#*'S)(>C,V$-\%_T!_4Q!
M(5X"&85H)=1B'HK_)!*D@XBK.CH6'8$SE73@OI:@R31U:A!O;%0V<=10J([#
M0 #Q^T9S$V&$=4!%HJ,ZX !FJ?FUV"J:GPWM-L80KU&J((FN1!<XBH!M3:0E
MT 67&Z"D'[\&$J6E!2L*OZ,2&20A,&&$O&#C5>ZZ.KP."VMM$<#LL=9Z.? <
MMG%D6<%%2E%2!1[.= NN!SD'40_,\NB*X"2A1VMR*T$ 9\*&1&'CV$Q,!+R5
M$%AS]F!"^EP%6PB_R4*SC'%)^(0PI#;A=V%M-A6HLS^,L@9:Q,9E@D[!09 H
MB9_HEKER0B//9KF5DU3V@;N!<K@ :JS)(*EN"TJ^>%I3@)+PD-EE.T&&(,41
MJ\):3DV0HGE(5:C^P!<T0J@'ME=H*KHG%'$2!KE;] 4:'^[$O16831":TI?Q
MG=;#85^SE+:A=Z0<)Q*E:#_, #BLL41^5 S3?L"N<']A+3^_@:K/[]B-C*0V
MXK>B#1^%D1(9H>0,%#)?S Z^'O;B>+"_O8W;#U[G&TR+^P_;O-\-#K:_'B+N
M@%4,_,].BA^*['>XP^R6\?[@';!9T:$<IF.TDT$4O%OC8<@ 9NYK"=%7K;R.
M++>#ZL@%)T%SA.]O=8B]]TJES5GV=O;*M:V]1KUF)04]H!C45[FR^;"8578:
M6_5ZW>[YL(TV#[YI,]P.U3<1 N@,%S?:Q($!4LQ4^3@#1_O]OQGQEN1=I%DI
M%I.QA&!(NIP\.?#1X++5TW!+I%?G6L6@#%*R7X;2%4.:&M6^##8);=*H:;YR
MR''$!23U\6N9DH^I=UA8RYZ@YP<#'X!"\+(,<,;6(P[./7X R( ?4&&AI *I
MRZ5]F(X7^\!N2(Z_5/@-=!JP?@PD I,1,)UMURQJ4^XF.XIND$:-;LYTEB;$
MB4#7R[K+)W"S33:/4?NC*K:P=D_'[H_F+I]0QL%6IHJC,5\11[4\:PE%97P)
MQ<PU'!.>+S\6@"<\-.GSVV _TF"T-[_@<IZ],=4\LY>X_-AW@*H"Q0>W5-;?
M9GR;\?%W9!#LC)HR*\@CY2K%$F;V1BI6#HX.CR%H4)', FC5T7_)TZ+L83O4
M%9[:M=&_DK]QT/HZQC/8J__VCMU@(@,\GRU*T.Y3.=]&&2/SC>KFP38\:,IR
M9B+"DO44.[_X\ZIY.7?]X<,D?X>AW\#G=_OD\6ZYPO='@'H  ;UH7UMGE]MG
MK;-S=I[TVR*T6=ZG,=7C&>FQ564/X3NN+@:<;XT*>>"O!O/2TS&_$I@N 0=^
M_HV$!="=4E#76$Z1A'<'1U>')D%T]])+@/LR+I9]8&R#@(%R4@08?/XL;H0_
MAZIY2-]6G@CI7U)8_K6:-EM6@'>8RIGZM<3&&%(K7[AY*-[+W8R1WY-Q7B95
M/LCOPLMC.P *Y"]LM'DDH]R%@9)!'&V^*BRM"<6EHU@[AP_QQ;*QT7;NB4CQ
MT"=)RV-G-K?F=Q#F=@U>?E4G.4I&$SW237J%A+BT.33$O$E9-*OH\$JZ/?&J
MD#KF48]64B<.YW5:<^=ETF-=OX"Q$IW.^L)<V<:2#]",S/U IK=4+9=W*LV_
M=K:_MM+/.X]W&!"S4?=D2AWAXB:I /(PR]?6-0ZNG_T@VF'"0[,I7:YCMA93
M\(OSA [+SRTKPX?YRL7J[A "QDB,COO;<@+=8>#^IUR:!;:7 *VR3+K].CM<
MU5)Q:32; ZRRLU.O%:L[JPA9M5$I[E16#[+*3KFX6YL/KN=(G;P*>_-G*;,W
M?Y;*B[8WDZO!7[W!J2Q7<:ZVP6G45]?>5-[LS1Q:O0[:L[R:]J9<*U:6Q6?S
MV)L:^-7E^>#*VYN?.^(Y:NZF%@@^+]P"33SD\^H-4/7- +U%/#^B!6HTBO7&
M*D)6W:O.'5DLQ0*5Z\6].2WCSQKQ'!U7,WMSC(FO1=J;*4<U7[V]J2U7;ZZZ
MO5G=B*?V%O',96_*.\7=U;0WN[O%RBK&8E6PT-7YX'J+>%(+]*F26:!/&-$N
MU@)-/(+_ZBU0?;F:=,4M4'EU(Y[:6\0SEP6JU(J[*[B34G9JY49Q=V\%(2O5
MBHVW/9[9[,UE+;,WE[4%9]BF-5)Y+H/#EF!K=I:K,]]LS9NM68Y&;]2*>RN8
MPP+(:O65K'2H-8JU.4W@6["3&I_?ZYGQ^1V#QL4:GXFML5ZS[7ED<<0/:GO>
M,FT_C.VI54%@5Q&R:@.[P:T>9+6]XN[;QLYLEN:TD5F:T\:"+<W]UH;Z^1_!
MW#RR^/L'-3=OH<X/8VY*.\7*G(592S(W>^65#,(JM>)P9>Y;J#.' ?IW;E_G
MWY6%&Z")W6I?L^UY9!G>#VI[EE;>.K_MV7D+=>;2\.7=8GT%-?SJ0C;_2AZ,
MO#.I\-:O^V?HUUU]EG[=R'34=V^Q;T',->8;;> WVN OSSG6HR(>8^_9) \J
M=8K,P[7?UL<:>,U)Y6)>P/(_/<VIFF,IW[$1F"Y%>*^[9*X=9=I#4C?;S.0^
M+_4__,)55G#A3I1IT!R*#C8(9CRXP^Z9(;:&Q^:;23#@TJ-6X:&(XJ+I?TX=
M=@=\ZKW,],!.5[^PABW"VTE,,P*;^ EVSM6]/:FW!KC&<>Q3.VQJZ3FVW:D,
MJ+_I3\U+U17D)6IS*[M)J+MR4_=BW>PVSUQJ8'JW<^_O)(IMYW/[VK0IK]ZR
MW8IQR,+:Q*ZV;*ZFMM0!/S0,S*FUDFZ(GTY'C6T'V'LHQI^RIN%CWY0U4S_O
M2:P[P?@NK@NQ7HZV\-5MUH'8O#W,""V]AV[<V]8 )VQKGW^EVW G]J'72J1O
M2A@D893P8%K;X,+:<-]@O&U2D]]9NOO>)_B+-O=M5)ZGM^_>G+U]*[.VUMV=
M\'KDF=^OO+O(+J\[BQQL+LB>8Q/F-;=B'.EJ-$MB;-Y4TJHV8DS[UM';*;!)
MDNU;Q^9O#?@P49;2@D]_'<5'7[5(Z6_<-+<:WXR/O;H6?*;E'B!B>NW!IP4W
MV5LB-L"X>C8MFX"+MM0KV;^+?.F7V@28P4O*W!G[ZMGG470F2V]DL'6=;D1/
M.(>A/\R6N?_I,NX++?IXCKS[[MS4&TV+/F-@<#;>H\[ZS#+;9)91AUD=\PQ"
M9=YA!9]<X5'8E[U7>*8XR"FLY=().OIBO^[L[CCE^BY%=>CM3WTS\U""0;]Y
MYU;@>W=L7)</Y3"X@*\#1">-1RCO<,FQ.26,G1HTF^D0WP<0NE)TXPE?WD#P
MQQ\":NA=ST,QK'TS4F&-DB?Y@?"YO;I3W:LXC<9>L;RKW^)";S<&5+A^NS6@
MHK,FTS(O3AJ=9:09&]O:%,W8Y$N1M22N?C9&]H:G&PY6"%_FE(;/V4NB)Q 4
M+!>MCW['6=^\)'"6=VRGT"+H]&Z8=-H,MEN5P.>97E;HL$"E+PQ'OLP&,2^M
M&D\LWHE-Z#^9:9;R,J&Q8?SD%PF-8U']/K$Q"9%'K*RCWVTU-?-K%G4"81]F
M'ON.HX$(T8+B^YVF)(UFF_:!U,3]]X?_"%D#G<R<(VU0GS7JKT](&Y0>.<#3
M(OV7&^PM;;"P-SC\*.F#Q[['88E19-K16L^I>UI38L 8 GV];4*2M!7Z?5W]
M"D/HL<CKS[%"+-O6']8V9*@'_&M$U_CN)MCD;JS"MW3!(](%3VGX/7?*@#I_
MV_P<EA#F=$J^D'V61N"++>#:=:K5.D8[2XW#5Q_"N?,L,\%W+T^P8&?CE0C=
MH[H>/T+H\&C\+%(WPX&_A?+T;M6I5\NK+'4O!.%RI>YG-WZ/Z_WZ"#E\0A/8
MQ5;?5JM.M5Q:9<%[*1#?[-TSRMFC>E[.+6=/:GZY6)^MX90JE546LQ>"\,V^
M+57N'M7I[Q%R]X26?XOUVLK.3FFEY>Z%('RS;L\H98_J;_8(*7M*H[/%,O&.
M4VXT5EK,7@;"-_.V5,%[5&^G1PC>$YH\+92K:XVR4ZJN=/A6J=6=<GUOY26O
MUB@V=F=I-?!FXQ[?W&9N4;O?Y>:E1*U:J3J[C=HJB]IJ"]B;87N"M#VJD\<C
MI.T)+3T6RLJ-:L/9J^Z^2=M2I:WPUKK@)VM=4'N6U@7/!SM6C&)5MQ?R6^XS
MCPYXUO?QS&RQ7W3HUK]4^(T=8XEW#(\[6!?<3+I)9(I@RA7L&E0I9<<^1VHE
M68_C.?);K&N.(N$5V82J<GUHUE9[CIX%'5/7V^=W6*[K*[@OQ%I.BXHNAL:*
M<3P0+L*8PU]?]B76Z+A88=Z/J'P]8K=X=#Q?\9LC!\E^Q'B(QY3_D\A0'U[U
M^6V178]!E$J$Q?>!#*F<O%P!0A;6OD@OP('&4].<:07D$/,\82L[FK .2P)?
M1'C(F6B0.T"[017/7EH$JT>,F(R)-D 1^XRN]M7'=D\1PJPFRYS:74)]<DJO
M4] A$NN4/RG?0\I1<?[]\F+ R0/O UL"V!_M\B ^,LP7L<]>OY_6<@L+1ZP*
M:Z%PA;P1HR?#KU4,K)""K@\?1R)&=@?&-8<9.C*,8E-\S=L*AMG ,FI8#4/T
M<<,8RCO A-+MF:X'=!* "0(]*T<.15\F?09<"*, >K]28R2<??K!^!F.PNNB
M^P?.PH]=FW'K$LRU$!-/UN>/F>NG<Z0C6BR/;5%=&?U@$7J /QPVF=5O>RH:
M.GP13JI!MUQ*YS?N'^DHK.6[:9 FR->VS]E-8ZASQG,>*=*:"VV"P,8/>")#
M49>$A+I &,Z/,O"0)OD^(2D'/I;/K/HLLA82[=Z$,C(G>S1LRG63\)[5V]7*
M^3Z?CA VE?$H:?^-C2Y@1 [KBH_E>D.,/V: IVKP/ ^>JRFL18!0U)$ %6!\
MRT%7Y7%Y[G6[)H#[ U_$TTTU<?2<I[WLB2K@9A'>F+X39'X=P#M'N4SNP H[
M>$E;.(?94\<"J4,'76XE"!KO"W,\)(696HV$M KC,7A^8IYU]'&O'N"L#S,Y
M(QTS]$DP%-\V>A]=&<7$]5F/$7,.&U5UTR590,3 K\'S5-EO0*>(W)60(H;1
M>;0/1;,H1%YS5P3*RJ[<UX#<IE9,#4%X.T+6UA 9+T+I<V_9VHCOHD^]7%@G
M5'V]F/D'C#<UU.!E&)W"&HDL=AS*&:;QN.7."5+L@F?=@%5&IC2^7#<46CC)
M[01^&QC6&B;+(%0WDL[2H?JQ+N2X$:>/P^<^^%C$4/%YN>_@#*19(I+H5H:@
MAWF$A^J($6 EB1$0ETB@C,#J4J&X*V.SWIVAN]K)G68]TQA@O'.,6J$M$-,^
M]_#$GR] 6X+^H@-BTVE"PJ("]#^4MG0#&!+U)OX@C?7[&V://.EJC8IN\/WF
M/,,*! 7][' )Y 878D!6B8ZV4O^CPAIHTWX2X D])"H 2QB"JX'+HFV/]H!#
M;8MXO,\VFIO: .'I5Z#Y%X&G9K1PIMHL"=5 P J=@H%1?>FR9B@X,]&9$>??
M@;X>R2;84;3&$E4[2H8Y(WD9*N+I)&(G! '8&X>A_RG)!LD ]'2L0M/7"$89
M@@7%PO!['V#!U=3@%=;&C4R8;AP9Y#;D9KK"-#0RCTIBS$B.0P)0VY#2/&P?
M'%9?]E9POV@T#3YI I#U#E"<PC_PF,$N(+0&@2:N&G!+N;%1W[04_@"&!MQH
M8-46F"OIFM.[7WCX3<1:'5?0V]Y(;R2L^PI7>I-=X$D,O*.>=Q_HJFVA!!@A
M(*-0U*KIP6:\V[%:W[+Q6YKIIT@SU5]9F@DT8&%-'S[6THFZ#22Q;S,5F;\&
M6KF3^#XE+S(%.>3X:/'90/$8L@6QZ@J:0YN9$)O9A$:/1D;(T-C=X+E>\U :
M15X/FVW4-Z2-;[CTN4X1.)E3 MK#&$/'V$$4Q-2W("O5UF;?P;/$8 JC4<?4
M)1](HS#L]U%J(NB"%))Q(T!0$3AL%'QP?@ :0U-4;=:(C][)HAX=@J<?M;<8
MHOU5IAF?I]R$0#<*!;2,!$T&!B1&)XV<DJF6<F]1@M@&/:_94OMU&9^/FW=G
M82&I,:L1<9UV&3 KE 2^<K\A/]&!<A4;'P4(U);*5]T[\A QV"1O-DJL\T*N
M+^92%!@Z6-4 K7J$'H\G(U?=T%T.N(<WPE<#^@S0)!U8GH0&(..O^TK@5QD$
MZH:3L>PE<"<"%/*!2, TD(</L(-[$RI,][3!4PUHLB0BX)4"V^;+;YCKO,'4
MIV=& =0%CH!,FP0A!VBTF=;!WG?M:0.Z #7YB3H#@;F,V)Z\[\!W#+1B-*!P
MJQ[9T&=)*06]?AW@8Z0R\#7'KE4$#3CJ '%?@*X1V!'!9X$PJ100$B!B%]M2
MQN"28=P/IC82),)QB,3NZ'@H,8$ZNB/@*X68X^L)[H/W#QP+Q#).@!?R/JP2
MS +B96\<" 6T1&6S\PZ7X0;[W3:10K%P>X'FHP%,($"51-1:H]S8*SDY0= ?
MT5/KANHV,-T+X GK$=RJT/?2*03W---X8B!HQW1D-EQ>\,NP.40/^RR&F"8$
MJ@")?<(4ADVYFH<J,6M-TVB_.\HQ+ZB<@1P MVJ B-#PV<1'Y$QP\"$R"2HN
M09E\4.$M#[VMSTJ1")-KJJ/.!TSV0O0*B60@;K,8"_4I1\'L&,A\ UF4098Z
MO&V.48!IPP*A58B+J#-3W,0XL IMH+GHT'*93% 3#6,ZGI-V_0"1S$V#B5^
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M"?D15M)AGV.OZ)@0L[!V$8O_^OR@]75,>Y2]^F_OV UJ66"[+7+S]ZE Y!]
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M<?(77/QT_>7SX?\#4$L! A0#%     @ L*X-43B/ROX\!   ]!$  !$
M         ( !     &%M9VXM,C R,# X,3,N>'-D4$L! A0#%     @ L*X-
M46^ PZK@!0  %S8  !4              ( !:P0  &%M9VXM,C R,# X,3-?
M9&5F+GAM;%!+ 0(4 Q0    ( +"N#5%;:CD;^P<  *Q9   5
M  "  7X*  !A;6=N+3(P,C P.#$S7VQA8BYX;6Q02P$"% ,4    " "PK@U1
M- .PW)H%  #B.0  %0              @ &L$@  86UG;BTR,#(P,#@Q,U]P
M<F4N>&UL4$L! A0#%     @ L*X-4?(GYX<$$   7G<   T
M ( !>1@  &0Y-C T,60X:RYH=&U02P$"% ,4    " "PK@U1"3K==MHB   1
MK0  $               @ &H*   9#DV,#0Q9&5X.3DQ+FAT;5!+ 0(4 Q0
M   ( +"N#5$:X63HVR0  .[N   0              "  ;!+  !D.38P-#%D
?97@Y.3(N:'1M4$L%!@     '  < OP$  +EP      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
